Other studies have shown that an TNF-α blocker had an antiapoptotic effect on human salivary gland epithelial cells which is a significant pathological environment for SS [46], and suppressed inflammation in the lacrimal gland and cornea in dry eye treatment [47]. This evidence concerns the gene TNF and synovial sarcoma.